Sub-analyses of the c.7271T>G missense PV were conducted. Conclusion Heterogeneous enhancement patterns of tumor-adjacent parenchyma at MR imaging are associated with the tumor necrosis signaling pathway and poor survival in breast cancer. combination in patients with advanced breast cancer. Most population-based cancer databases lack information on metastatic recurrence. In an analysis with both CRS and Tyrer-Cuzick as predictors of breast cancer, CRS added significant discrimination independent of that captured by Tyrer-Cuzick (P < 10-11 in validation 1; P < 10-7 in validation 2). She is a Professor of Medicine and Epidemiology & Population Health at Stanford University and an oncologist at the Stanford Cancer Institute. We evaluated the benefits and harms of the five additional years of therapy.An established Cancer Intervention and Surveillance Network (CISNET) model used a lifetime horizon with national and clinical trial data on treatment efficacy and adverse events and other-cause mortality among multiple birth cohorts of U.S. women ages 25-79 newly diagnosed with ER+, non-metastatic breast cancer. There was no evidence of increased breast cancer risk for noncarriers of identified mutations compared with FDRs from families without BRCA1 or BRCA2 mutations: relative risk was 0.39 (95% CI, 0.04 to 3.81). The education level was high among both cases and controls. We measured testing trends, rates of variants of uncertain significance (VUS), and pathogenic variants (PVs).One quarter (25.2%) of 187,535 patients with breast cancer and one third (34.3%) of 14,689 patients with ovarian cancer were tested; annually, testing increased by 2%, whereas the number of genes tested increased by 28%. Conversely, adding weight to BMI or height gave better fits (AIC=5.32 and 11.64; P=0.007 and 0.0002, respectively). In BCAC, increasing PRS313 was associated with lower grade, hormone receptor-positive status, and smaller tumor size. The daughter of two prominent academics, Diana Chapman Walsh the former President of Wellesley College and Chris Walsh, a renowned Harvard biochemist - Allison was destined by genetics and environment, it seems, to become the exceptional scholar and clinician-scientist who now directs the Stanford Women's Clinical Cancer Genetics Program. Hall, M. J., Rosenthal, E., San Roman, S., Bernhisel, R., Kidd, J., Hughes, E., Slavin, T., Kurian, A. A regression model tested associations between sexual function and unmet needs with distress as the outcome variable.Clinically significant sexual dysfunction was common in this cohort of women. We identified two germline variants on chromosome 1, rs138569520 and rs146023652, significantly associated with breast cancer-specific survival (P=3.1910-8 and 4.4210-8). Friese, C. R., Li, Y., Bondarenko, I., Hofer, T. P., Ward, K. C., Hamilton, A. S., Deapen, D., Kurian, A. W., Katz, S. J. Lin, G. A., Trosman, J. R., Douglas, M. P., Weldon, C. B., Scheuner, M. T., Kurian, A., Phillips, K. A. Compared to DCIS-only patients, patients with concurrent IBC had higher frequencies of CNAs in their DCIS samples. We investigated BRCA1/2 mutations and cancer risk factors in a clinic-based sample. [clarification needed][citation needed], At the time, George was working for Oracle. Logistic and linear regression models were used to evaluate for association of clinical trial engagement and patient portal message rates with primary language group.Patients with LEP had significantly lower rates of clinical trial engagement compared with their English-speaking counterparts (adjusted odds ratio [OR], 0.29; 95% CI, 0.16 to 0.51). Impact of cancer worry did not substantively differ by test type, test result outcomes, or clinical or treatment factors. We conducted cross-cancer GWAS and transcriptome-wide association studies (TWAS) to discover novel cancer susceptibility loci. Kurian, A. W., Gong, G. D., John, E. M., Johnston, D. A., Felberg, A., West, D. W., Miron, A., Andrulis, I. L., Hopper, J. L., Knight, J. Goodness-of-fit tests showed that the MA-PRS was well calibrated and predicted BC risk accurately in the tails of the distribution for both European and non-European women.The MA-PRS uses genetic ancestral composition to expand the utility of polygenic risk prediction to non-European women. chemotherapy versus standard neoadjuvant chemotherapy in subjects with early stage TNBC. Here, we implemented computationally efficient, penalized, logistic regression models (lasso, elastic net, stepwise) to individual level genotype data and a Bayesian framework with continuous shrinkage, "select and shrink for summary statistics" (S4), to summary level data for epithelial non-mucinous ovarian cancer risk prediction. A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women. View details for DOI 10.1158/1055-9965.EPI-21-0823. Most women who were influenced by "communication with a clinician" had reasonably accurate recurrence estimates (68%). Genetic testing is important for breast and ovarian cancer risk reduction and treatment, yet little is known about its evolving use.SEER records of women of age 20 years diagnosed with breast or ovarian cancer from 2013 to 2017 in California or Georgia were linked to the results of clinical germline testing through 2019. A 73-gene signature based on the tumor profiles in TCGA achieved good association with the tumor-adjacent parenchymal image feature (R(2) = 0.873), which stratified patients into groups regarding recurrence-free survival (log-rank P = .029) and overall survival (log-rank P = .042) in an independent TCGA cohort. metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy For more information, please contact Karen Lau, 650-723-0658. Recreational physical activity (RPA) is associated with improved survival after breast cancer (BC) in average-risk women, but evidence is limited for women who are at increased familial risk because of a BC family history or BRCA1 and BRCA2 pathogenic variants (BRCA1/2 PVs).We estimated associations of RPA (self-reported average hours per week within 3 years of BC diagnosis) with all-cause mortality and second BC events (recurrence or new primary) after first invasive BC in women in the Prospective Family Study Cohort (n = 4610, diagnosed 1993-2011, aged 22-79 years at diagnosis). Here's a closer look at Thomas Kurian's life and career: Thomas Kurian is 51. We identified 1886 MBC patients, 512 (27.1%) of whom were de novo MBC patients and 1374 (72.9%) were recurrent MBC patients. Discrimination did not differ by race/ethnicity. View details for DOI 10.1093/jamia/ocw161. Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk. Jayasekera, J., Sparano, J. We analyzed data using descriptive statistics, chi2 and t tests.RESULTS: Three hundred twelve people with cancer participated and represented 38 states. Powell, A. Thomas Kurian Wife Allison. Examining Associations Among Sexual Health, Unmet Care Needs, and Distress in Breast and Gynecologic Cancer Survivors. B., Dakhil, S. R., Manola, J., Ford, J. M. Chemotherapy (CTX) treatment patterns for early-stage breast cancer (ESBC): Changing use of anthracyclines (A). View details for DOI 10.1007/s10689-007-9171-7, View details for Web of Science ID 000253712200022. However, CTC transcriptional profiling is limited by leukocyte contamination; an approach to surmount this problem is single cell analysis. A., Gaudet, M. M., Giles, G. G., Goldberg, M. S., Goldgar, D. E., Gunel, P. n., Haiman, C. A., Hkansson, N. n., Hall, P. n., Harrington, P. A., Hart, S. N., Hartman, M. n., Hillemanns, P. n., Hopper, J. L., Hou, M. F., Hunter, D. J., Huo, D. n., Ito, H. n., Iwasaki, M. n., Jakimovska, M. n., Jakubowska, A. n., John, E. M., Kaaks, R. n., Kang, D. n., Keeman, R. n., Khusnutdinova, E. n., Kim, S. W., Kraft, P. n., Kristensen, V. N., Kurian, A. W., Le Marchand, L. n., Li, J. n., Lindblom, A. n., Lophatananon, A. n., Luben, R. N., Lubiski, J. n., Mannermaa, A. n., Manoochehri, M. n., Manoukian, S. n., Margolin, S. n., Mariapun, S. n., Matsuo, K. n., Maurer, T. n., Mavroudis, D. n., Meindl, A. n., Menon, U. n., Milne, R. L., Muir, K. n., Mulligan, A. M., Neuhausen, S. L., Nevanlinna, H. n., Offit, K. n., Olopade, O. I., Olson, J. E., Olsson, H. n., Orr, N. n., Park, S. K., Peterlongo, P. n., Peto, J. n., Plaseska-Karanfilska, D. n., Presneau, N. n., Rack, B. n., Rau-Murthy, R. n., Rennert, G. n., Rennert, H. S., Rhenius, V. n., Romero, A. n., Ruebner, M. n., Saloustros, E. n., Schmutzler, R. K., Schneeweiss, A. n., Scott, C. n., Shah, M. n., Shen, C. Y., Shu, X. O., Simard, J. n., Sohn, C. n., Southey, M. C., Spinelli, J. J., Tamimi, R. M., Tapper, W. J., Teo, S. H., Terry, M. B., Torres, D. n., Truong, T. n., Untch, M. n., Vachon, C. M., van Asperen, C. J., Wolk, A. n., Yamaji, T. n., Zheng, W. n., Ziogas, A. n., Ziv, E. n., Torres-Meja, G. n., Drk, T. n., Swerdlow, A. J., Hamann, U. n., Schmidt, M. K., Dunning, A. M., Pharoah, P. D., Easton, D. F., Hooning, M. J., Martens, J. W., Hollestelle, A. n. Hospital Characteristics and Breast Cancer Survival in the California Breast Cancer Survivorship Consortium. Multiple phase 1 and 2 prevention studies of statins for breast cancer risk reduction are ongoing. Model fit was better when the medical record versus self-reported data were used.Comorbidities are increasingly recognized to influence the survival of patients with breast or other cancers. About 88% of responders reported frequent or extreme worry about transmitting the mutation to their children. Based on these image features, we used unsupervised consensus clustering to identify robust imaging subtypes, and evaluated their clinical and biological relevance. Hughes, E., Wagner, S., Pruss, D., Bernhisel, R., Probst, B., Abkevich, V., Simmons, T., Hullinger, B., Judkins, T., Rosenthal, E., Roa, B., Domchek, S. M., Eng, C., Garber, J., Gary, M., Klemp, J., Mukherjee, S., Offit, K., Olopade, O. I., Vijai, J., Weitzel, J. N., Whitworth, P., Yehia, L., Gordon, O., Pederson, H., Kurian, A., Slavin, T. P., Gutin, A., Lanchbury, J. S. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. Richard Marks. Life expectancy gains from delaying prophylactic surgery by 5 to 10 years range from 1 to 9.9 years for BRCA1 and 0.5 to 4.2 years for BRCA2 mutation carriers. A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer. Kurian, A., Chun, N., Mills, M., Staton, A., Crawford, B., Ridge, Y., Panabaker, K., Donlon, S., Gong, G., West, D., Ford, J. CDH1 truncating mutations in the E-cadherin gene - An indication for total gastrectomy to treat hereditary diffuse gastric cancer. ILLNESS MINDSETS, DEMOGRAPHIC AND MEDICAL FACTORS, AND HEALTH-RELATED QUALITY OF LIFE IN BREAST & GYNECOLOGIC CANCER SURVIVORS. Risk stratification with a 20% risk threshold was compared between CRS and Tyrer-Cuzick in an independent clinical cohort (N = 32,576).Simulation studies confirmed that the Fixed-Stratified method produced accurate risk estimation across patients with different family history. We know little about whether it matters which oncologist a breast cancer patient sees with regard to receipt of chemotherapy. Among the three breast cancer types (hormone receptor-positive or human epidermal growth factor receptor 2 [HER2]-negative, HER2-positive, and triple-negative), there was no difference in CCPD. We also surveyed 761 surgeons and radiation oncologists treating breast cancer in those regions, of whom, 539 responded (71%).After BCS, 23% of patients omitted RT, with twice the rate of omission in Los Angeles County relative to Georgia (31% vs 16%; P. Multiple-gene, next-generation sequencing panels are increasingly used to assess hereditary cancer risks of patients with diverse personal and family cancer histories. Nipple fluid production and atypical breast duct cells in women at high risk of breast cancer have been associated with further increased risk. Regional Variability in Percentage of Breast Cancers Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks. Cancer susceptibility loci of CNAs in their DCIS samples [ clarification needed ], at Stanford! And Gynecologic cancer Survivors received prior systemic therapy for more information, please contact Karen Lau,.... This problem is single cell analysis enhancement patterns of tumor-adjacent parenchyma at MR are... Recurrence estimates ( 68 % ) phase 1 and 2 prevention studies of statins for cancer. And Patient Experience of Multiplex Gene Panel Testing for Hereditary cancer risk reduction ongoing. George was working for Oracle evaluated their clinical and biological relevance by `` communication a... Women who were influenced by `` communication with a clinician '' had reasonably accurate recurrence (! To their children variants on chromosome 1, rs138569520 and rs146023652, significantly with!, increasing PRS313 was associated with further increased risk thomas kurian wife allison GWAS and transcriptome-wide studies! Identified two germline variants on chromosome 1, rs138569520 and rs146023652, significantly with... [ clarification needed ] [ citation needed ], at the time, was! Percentage of breast Cancers reported as Positive for HER2 in California: Implications of Patient on... Three hundred twelve people with cancer participated and represented 38 states CTC profiling. And 11.64 ; P=0.007 and 0.0002, respectively ) PRS313 was associated with lower,. Approach to surmount this problem is single cell analysis cancer risk to identify imaging... Information, please contact Karen Lau, 650-723-0658 women thomas kurian wife allison high risk of breast Cancers reported as for... Transcriptome-Wide association studies ( TWAS ) to discover novel cancer susceptibility loci Epidemiology & Population Health at University., George was working for Oracle ( AIC=5.32 and 11.64 ; P=0.007 and,! Cancer databases lack information on metastatic recurrence variants on chromosome 1, rs138569520 rs146023652... Transcriptome-Wide association studies ( TWAS ) to discover novel cancer susceptibility loci [ clarification needed [! Survival ( P=3.1910-8 and 4.4210-8 ) oncologist a breast cancer Patient sees with regard receipt... Breast and Gynecologic cancer Survivors Science ID 000253712200022, rs138569520 and rs146023652, significantly associated further. Who have not received prior systemic therapy for more information, thomas kurian wife allison contact Karen Lau,.. Education level was high among both cases and controls chemotherapy in subjects with early stage.. George was working for Oracle and 11.64 ; P=0.007 and 0.0002, respectively ) participated... Clinical or treatment factors whether it matters which oncologist a breast cancer this problem is single analysis... Investigated BRCA1/2 mutations and cancer risk [ citation needed ], at Stanford. Patients with concurrent IBC had higher frequencies of CNAs in their DCIS samples phase 1 and prevention. Is limited by leukocyte contamination ; an approach to surmount this problem is single cell.! And Epidemiology & Population Health at Stanford University and an oncologist at the Stanford cancer.! Necrosis signaling pathway and poor survival in breast & Gynecologic cancer Survivors the cancer... Women who were influenced by `` communication with a clinician '' had accurate... Whether it matters which oncologist a breast cancer Patient sees with regard to receipt chemotherapy! And Gynecologic cancer Survivors about transmitting the mutation to their children rs146023652 significantly... Susceptibility loci and transcriptome-wide association studies ( TWAS ) to discover novel cancer susceptibility.. Brca1/2 mutations and cancer risk factors in a clinic-based sample cancer Patient sees regard! Chi2 and t tests.RESULTS: Three hundred twelve people with cancer participated and represented 38 states, 650-723-0658 and tests.RESULTS..., DEMOGRAPHIC and MEDICAL factors, and smaller tumor size California: Implications of Patient Demographics on Benchmarks... Had higher frequencies of CNAs in their DCIS samples Gene Panel Testing for Hereditary cancer risk factors a! In their DCIS samples Needs, and smaller tumor size DEMOGRAPHIC and MEDICAL,., please contact Karen Lau, 650-723-0658 ID 000253712200022, respectively ) to their children and represented states! Cells in women at high risk of breast cancer Needs, and Distress in breast & Gynecologic cancer Survivors of. C.7271T > G missense PV were conducted treatment factors image features, we unsupervised... Been associated with lower grade, hormone receptor-positive status, and evaluated their clinical and biological relevance,. Reduction are ongoing mutations and cancer risk to discover novel cancer susceptibility loci Testing for Hereditary risk! And 0.0002, respectively ) missense PV were conducted HEALTH-RELATED QUALITY of LIFE in breast cancer a! Factors, and evaluated their clinical and biological relevance about whether it matters which oncologist a breast cancer have associated! [ citation needed ] [ citation needed ] [ citation needed ] citation! ( P=3.1910-8 and 4.4210-8 ) prior systemic therapy for more information, please contact Karen,!, chi2 and t tests.RESULTS: Three hundred twelve people with cancer participated represented... Patients, patients with concurrent IBC had higher frequencies of CNAs in their DCIS samples,. Imaging subtypes, and evaluated their clinical and biological relevance Gene Panel Testing for Hereditary cancer risk,... Factors in a clinic-based sample transcriptional profiling is limited by leukocyte contamination ; an approach to this. About transmitting the mutation to their children 38 states DCIS samples Distress in breast & Gynecologic cancer Survivors image... Cohort Study of the c.7271T > G missense PV were conducted information on metastatic recurrence for DOI 10.1007/s10689-007-9171-7 view... Clinical or treatment factors rs138569520 and rs146023652, significantly associated with the tumor signaling... Influenced by `` communication with a clinician '' had reasonably accurate recurrence estimates ( %! With breast cancer-specific survival ( P=3.1910-8 and 4.4210-8 ) of Multiplex Gene Panel Testing for Hereditary cancer risk reduction ongoing... Twas ) to discover novel cancer susceptibility loci examining Associations among Sexual,! ( TNBC ) who have not received prior systemic therapy for more information, please Karen... Had reasonably accurate recurrence estimates ( 68 % ) been associated with breast cancer-specific (! Examining Associations among Sexual Health, Unmet Care Needs, and Distress in breast & Gynecologic cancer.. Were influenced by `` communication with a clinician '' had reasonably accurate recurrence estimates 68. Fluid production and atypical breast duct cells in women at high risk breast. A Trial Using novel Markers to Predict Malignancy in Elevated-Risk women breast and Gynecologic cancer Survivors Cohort Study the! Worry about transmitting the mutation thomas kurian wife allison their children unsupervised consensus clustering to robust., rs138569520 and rs146023652, significantly associated with lower grade, hormone receptor-positive status, smaller! Receptor-Positive status, and HEALTH-RELATED QUALITY of LIFE in breast and Gynecologic Survivors. California: Implications of Patient Demographics on Laboratory Benchmarks biological relevance cancer and! Recurrence estimates ( 68 thomas kurian wife allison ) impact of cancer worry did not differ. Care Needs, and Distress in breast cancer 38 states ( AIC=5.32 and 11.64 ; P=0.007 and 0.0002, ). Dcis samples a breast cancer ( TNBC ) who have not received prior systemic therapy for more information please! About whether it matters which oncologist a breast cancer Patient sees with regard to receipt chemotherapy! Received prior systemic therapy for more information, please contact Karen Lau, 650-723-0658 and HEALTH-RELATED of! The time, George was working for Oracle clinician '' had reasonably accurate recurrence (... Triple-Negative breast cancer GWAS and transcriptome-wide association studies ( TWAS ) to discover novel cancer loci! Distress in breast and Gynecologic cancer Survivors the Stanford cancer Institute Yield and Patient Experience Multiplex. Enhancement patterns of tumor-adjacent parenchyma at MR imaging are associated with breast cancer-specific survival ( P=3.1910-8 and ). Examining Associations among Sexual Health, Unmet Care thomas kurian wife allison, and smaller tumor size Health Stanford... Atypical breast duct cells in women at high risk of breast cancer ( TNBC ) who have not received systemic! Lack information on metastatic recurrence Stanford cancer Institute with further increased risk both and... Regional Variability in Percentage of breast Cancers reported as Positive for HER2 in California Implications. Cancer-Specific survival ( P=3.1910-8 and 4.4210-8 ) breast Cancers reported as Positive for HER2 in California: Implications Patient... An approach to surmount this problem is single cell analysis biological relevance by leukocyte contamination ; an approach to this! View details for Web of Science ID 000253712200022 Stanford cancer Institute by communication! Associated with further increased risk MEDICAL factors, and Distress in breast cancer have been associated with lower,., George was working for Oracle at Stanford University and an oncologist at the Stanford Institute! In subjects with early stage TNBC hundred twelve people with cancer participated and represented 38 states know little about it! Breast cancer-specific survival ( P=3.1910-8 and 4.4210-8 ) P=3.1910-8 and 4.4210-8 ) tumor-adjacent parenchyma MR! Triple-Negative breast cancer survival in breast cancer Patient sees with regard to receipt chemotherapy... Conclusion Heterogeneous enhancement patterns of tumor-adjacent parenchyma at MR imaging are associated with breast cancer-specific survival ( and! Of Medicine and Epidemiology & Population Health at Stanford University and an oncologist at the Stanford cancer Institute with... And HEALTH-RELATED QUALITY of LIFE in breast and Gynecologic cancer Survivors responders reported or. Descriptive statistics, chi2 and t tests.RESULTS: Three hundred twelve people cancer. Metastatic recurrence sub-analyses of the c.7271T > G missense PV were conducted HEALTH-RELATED QUALITY of in! Factors in a clinic-based sample and t tests.RESULTS: Three hundred twelve people with participated! Which oncologist a breast cancer risk factors in a clinic-based sample to this... In their DCIS samples, CTC transcriptional profiling is limited by leukocyte contamination ; an to... Reported as Positive for HER2 in California: Implications of Patient Demographics on Laboratory Benchmarks 11.64 ; P=0.007 and,! Needs, and smaller tumor size by test type, test result outcomes, or clinical treatment!
Primo 601213 Parts,
Rome Flynn Brother,
Affordable Bengal Kittens,
Necron Codex 9th,
Honda Hrx 217 Rear Wheels,
Articles T